PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24822F0151Infectious disease PCR reagents and consumables — Abbott Molecular Inc

Abbott Molecular Inc holds $41.3M across 47 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent V797D40222. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

248-Network Contract Office 8 (36C248)
Awarding office
Abbott Molecular Inc
Recipient
Sep 30, 2026
PoP end
$3M
Obligated
$5.5M
Potential
325413
NAICS
6640
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Abbott Molecular Inc — $90

Contract facts

Federal
Contract number36C24822F0151
Also listed as36C248-22-F-0151
Also listed asV797D40222-36C24822F0151
Agency248-Network Contract Office 8 (36C248)
Awarding office248-Network Contract Office 8 (36C248)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentAbbott Molecular Inc
CAGE44Z73
UEINK5QDVJBHMN7
NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6640
Parent IDIQ / IDVV797D40222
Place of performanceDES PLAINES IL
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startMar 14, 2022
PoP end (current)Sep 30, 2026
Obligated$3M
Current value$3.5M
Potential value$5.5M

INFECTIOUS DISEASE PCR REAGENTS AND CONSUMABLES is a federal award for 248-Network Contract Office 8 (36C248) held by Abbott Molecular Inc. Estimated value $5.5M ($3M obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: DES PLAINES IL.

INFECTIOUS DISEASE PCR REAGENTS AND CONSUMABLES

Recompete timing

Public
Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Abbott Molecular Inc$41.3M obligated across 47 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($41.3M) · all agencies · Top 3 shown (29%); remaining ~71% is other agencies.
Department of Veterans Affairs (VA)$9.6M · 23%Department of Defense (DOD)$1.7M · 4%Department of Health and Human Services (HHS)$756K · 2%
Open full company profile

Related awards

Same parent · incumbent
75D30125P20640
ABBOTT ASPS SMPL PUR KIT PLATFORM
$122K
Aug 30, 2026
36C24125N0827
ALINITY M COVID TESTING, HIV TESTING, HPV TESTING SUPPLIES DELIVERY ORDER
$450K
Sep 21, 2026
36C24121N1147
ALINITY M COVID TESTING, HIV TESTING, HPV TESTING SUPPLIES
$384K
Sep 21, 2026
HT001425PE034
SPECIALIZED FISH PROBES COMPATIBLE WITH EXISTING DIAGNOSTIC EQUIPMENT UTILIZED BY THE MOLE…
$141K
Sep 29, 2026
36C24222N0177
ALINITY-M REAGENT KITS AND CONSUMABLES BASE YEAR
$4.0M
Sep 30, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C24822F0151?

36C24822F0151 (Infectious disease PCR reagents and consumables) is a 248-Network Contract Office 8 (36C248) award with a potential value of $5.5M, currently held by Abbott Molecular Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C248-22-F-0151?

36C248-22-F-0151 is the dashed form of PIID 36C24822F0151 (Infectious disease PCR reagents and consumables), held by Abbott Molecular Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24822F0151?

248-Network Contract Office 8 (36C248) awarded 36C24822F0151 to Abbott Molecular Inc (potential $5.5M).

Who is the incumbent on 36C24822F0151?

Abbott Molecular Inc is the incumbent with $41.3M across 47 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Abbott Molecular Inc’s 36C24822F0151 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C24822F0151